Correction: Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer
Oncotarget
.
2021 Jun 22;12(13):1325.
doi: 10.18632/oncotarget.28004.
Authors
Edna Gordian
1
2
,
Eric A Welsh
3
2
,
Nicholas Gimbrone
4
,
Erin M Siegel
5
,
David Shibata
6
,
Ben C Creelan
7
,
William Douglas Cress
4
,
Steven A Eschrich
8
,
Eric B Haura
7
,
Teresita Muñoz-Antonia
1
Affiliations
1
Tumor Biology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
2
These authors contributed equally to this work.
3
Cancer Informatics Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
4
Molecular Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
5
Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
6
Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, USA.
7
Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
8
Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
PMID:
34194632
PMCID:
PMC8238243
DOI:
10.18632/oncotarget.28004
Abstract
[This corrects the article DOI: 10.18632/oncotarget.26574.].
Copyright: © 2021 Gordian et al.
Publication types
Published Erratum